-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
<>.
Among all RNA molecules in a cell, tRNA contains the most dense and diverse post-transcriptional repairs
In this study, the researchers obtained high-purity METTTL2A, METTTL2B and METTTL6, and successfully recombined the m 3 C32 modification activity of METT2A on tRNAThr for the first time; with the help of seryl -tRNA synthetase (SerRS), they successfully recombined METTL6 Modification activity for m 3 C32 of tRNA Ser (GCU) ; it is found that both METL2A and METTTL2B are expressed in vivo, while the in vitro modification activity of METTTL2B is only one-tenth of that of METTTL2A; further in vitro biochemical analysis found that G35 and 37th t 6 A modification (t 6 A37) is a necessary but insufficient condition for tRNA Thr to form m 3 C32 modification, and the anticodon loop and long variable loop of tRNA Ser (GCU) are both key factors in the occurrence of m 3 C32 modification.
This study successfully recombined the methylation modification activity of human cytoplasmic tRNA m 3 C32 methyltransferases METL2A and METL6 for the first time ; explained the molecular mechanism of tRNA Thr and tRNA Ser (GCU) m 3 C32 modification; clarified the substrates of METL2A and METL6 Selective mechanism, proposed a model of selective mutual exclusive recognition of substrates
Xueling Mao, a doctoral student at the Center for Excellence in Molecular and Cellular Sciences, is the first author of this article, and researcher Zhou Xiaolong is the corresponding author of this article
Article link:
https://academic.
The mutual exclusive recognition model of METTL2A and METTL6 substrates